PeptidePedia The community reference

Contributions of ReportReaderRilla

User contributions·54 logged edits·page 1 of 1

Contributions by ReportReaderRilla, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,422 edits includes activity predating the current log.

  1. 18:01, 24 Jun 2026 (diff | hist) Shanghai Wibson Biotechnology 15,440 ±0 add the lead time for catalogue lines, as reported
  2. 18:42, 15 Jun 2026 (diff | hist) Crude peptide 4,775 ±0 rm the shipping recommendation — that is advice, not description
  3. 02:27, 12 Jun 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 17,716 ±0 rm the price; supplier articles carry no price per PP:VN
  4. 20:53, 10 Jun 2026 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 close an unbalanced quotation mark
  5. 11:15, 5 Jun 2026 (diff | hist) Talk:Janoshik Analytical 674 +166 /* Should content determination be described as an option? */ new section
  6. 03:02, 28 May 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 17,716 ±0 m add the transit window each regional warehouse serves
  7. 06:54, 21 May 2026 (diff | hist) Medutest 5,018 ±0 m state the date range the submitted set covers
  8. 18:08, 20 May 2026 (diff | hist) Wuhan Wansheng Biotechnology 15,849 ±0 m add the note that self-published material is usable only for what it states about itself
  9. 14:19, 6 May 2026 (diff | hist) SinoPep 18,360 ±0 typo
  10. 13:49, 3 May 2026 (diff | hist) Flourishglobal Peptide Biotech 14,771 ±0 m rm the adjective — an organisation article describes, it does not praise
  11. 18:28, 15 Apr 2026 (diff | hist) Purity claim inflation 5,660 ±0 give the fields a compendially-complete certificate would carry
  12. 11:20, 13 Apr 2026 (diff | hist) Talk:Test report forgery 537 +166 /* Absence of signals establishes nothing */ new section
  13. 05:08, 7 Apr 2026 (diff | hist) Growth hormone secretagogue 4,613 ±0 m add the parent protein and the residue range the fragment spans
  14. 18:45, 23 Mar 2026 (diff | hist) Intention-to-treat analysis 4,963 ±0 m the percentage quoted was placebo-adjusted; label it
  15. 14:45, 21 Mar 2026 (diff | hist) Talk:VendorInvestigate 748 +123 /* Forgery limitation */ reply
  16. 15:44, 15 Mar 2026 (diff | hist) PeptideMeter 4,925 ±0 m split §What a report shows from §What it does not
  17. 06:50, 19 Jan 2026 (diff | hist) AmbioPharm 13,391 +1,625 add the how-to-request-a-batch-record sentence to §Ordering and availability
  18. 08:45, 9 Jan 2026 (diff | hist) Talk:Third-party testing 822 +111 /* The three questions */ reply
  19. 13:34, 30 Dec 2025 (diff | hist) PolyPeptide Group (Hangzhou) 14,415 +1,223 state the city and province of the registered address
  20. 07:16, 28 Dec 2025 (diff | hist) Zhuhai Kerui Biotechnology 12,918 +798 m add the incorporation year, attributed to the registry record
  21. 12:03, 1 Dec 2025 (diff | hist) Methionine oxidation 5,001 ±0 correct the flow rate — the source gives it in mL/min
  22. 18:40, 25 Nov 2025 (diff | hist) SinoPep 13,168 +1,327 clarify that no manufacturing or marketing authorisation is claimed or established
  23. 04:27, 18 Nov 2025 (diff | hist) Patent expiry and biosimilars 4,553 ±0 m attribute the enforcement statement to the published policy
  24. 05:49, 10 Nov 2025 (diff | hist) Bacteriostatic water 4,652 ±0 add the sharps-disposal cross-link
  25. 16:42, 30 Oct 2025 (diff | hist) PolyPeptide Group (Hangzhou) 8,468 +381 m add category for suppliers in China
  26. 16:02, 29 Oct 2025 (diff | hist) GenScript Peptides 8,581 +578 m add the transit window each regional warehouse serves
  27. 08:04, 28 Oct 2025 (diff | hist) USP General Chapter 85 5,180 +260 rm the claim that the method is stability-indicating without a forced-degradation study
  28. 02:23, 17 Oct 2025 (diff | hist) Guangzhou JEEP Biotechnology 15,232 +1,157 add the see-also to the certificate-of-analysis article
  29. 15:10, 26 Aug 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 12,550 +413 m move a stray full stop inside the reference
  30. 23:54, 23 Aug 2025 (diff | hist) Hunan Aslsen Technology 12,908 +207 m expand §Reception
  31. 05:51, 20 Aug 2025 (diff | hist) Peptide supply chain 8,147 ±0 clarify that the cake appearance is an indicator, not a specification
  32. 18:30, 9 Aug 2025 (diff | hist) Lot traceability 5,087 ±0 add the point that reports reaching this wiki are not a sample of anything
  33. 01:14, 19 Jul 2025 (diff | hist) Mass spectrometry 5,612 ±0 correct the flow rate — the source gives it in mL/min
  34. 17:43, 8 Jul 2025 (diff | hist) Shanghai ERP Biotechnology 2,993 +1,264 clarify that a registered business scope is a licensing fact, not a quality assurance
  35. 00:27, 27 Jun 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 3,239 +747 move a stray full stop inside the reference
  36. 07:19, 17 Jun 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 7,638 +673 expand §Independent testing record
  37. 14:35, 17 May 2025 (diff | hist) Qingdao Sigma Chemical 11,582 +959 add the note that self-published material is usable only for what it states about itself
  38. 19:46, 13 May 2025 (diff | hist) Nantong Guangyuan Chemical 10,347 +54 clarify that no manufacturing or marketing authorisation is claimed or established
  39. 15:12, 14 Apr 2025 (diff | hist) Talk:Blind sampling 748 +155 /* Selection on the outcome is a third failure, not a footnote */ reply
  40. 08:40, 26 Mar 2025 (diff | hist) Talk:Peptide content 959 +204 /* Which convention does a nominal fill follow? */ reply
  41. 19:33, 2 Mar 2025 (diff | hist) Bachem Holding (Suzhou) 8,899 +798 expand §Corporate identity and history
  42. 06:56, 7 Feb 2025 (diff | hist) Liquid chromatography-mass spectrometry 3,451 +136 m expand §Quantification
  43. 02:08, 8 Jan 2025 (diff | hist) LEADER trial 3,178 +45 m add the discontinuation rate for adverse events in both arms
  44. 00:31, 28 Dec 2024 (diff | hist) Guangzhou JEEP Biotechnology 7,805 ±0 correct the trading name — the short code and the legal name are different things
  45. 17:07, 15 Dec 2024 (diff | hist) Tianjin Finder Chemical 4,570 +798 expand §Notability and coverage
  46. 02:43, 2 Dec 2024 (diff | hist) Underfilling 1,727 ±0 add the note that self-submitted reports are a self-selected sample
  47. 05:50, 6 Nov 2024 (diff | hist) WuXi TIDES 5,922 ±0 m convert a hard-coded date to the house format
  48. 17:29, 10 Oct 2024 (diff | hist) Peptide 3,677 ±0 correct the eutectic temperature — source gives a range
  49. 20:12, 26 Sep 2024 (diff | hist) Chinese Peptide Company 4,325 +207 add the see-also to the certificate-of-analysis article
  50. 06:08, 17 Sep 2024 (diff | hist) Dual incretin agonist 3,231 +40 m the half-life in the lead was the terminal figure; label it as such
  51. 18:27, 16 Sep 2024 (diff | hist) Guangzhou JEEP Biotechnology 4,643 +33 correct the other-designations row — those are trading variants, not subsidiaries
  52. 09:05, 3 Sep 2024 (diff | hist) Talk:Certificate of analysis 822 +160 /* Is "a claim by its issuer" too strong? */ reply
  53. 23:15, 6 Aug 2024 (diff | hist) Chinese Peptide Company 2,218 +472 m rm the discount code added by an anonymous editor
  54. 16:07, 5 Aug 2024 (diff | hist) GL Biochem (Shanghai) 4,280 +696 space between number and unit per PP:MOS